Virtual Cardiovascular Nursing Symposium Schedule
All times are listed in Central Time.
WEDNESDAY, MAY 20 | |
---|---|
Start at 11:00 AM ET, 10:00 AM CT, 9:00 AM MT, 8:00 AM PT | |
10:00 AM | Welcome and PCNA Presidential Address Kim Newlin, RN, MS, CNS, ANP |
10:20 AM | Virtual Symposium Overview and Pre-Assessment |
10:30 AM | SGLT2 Inhibitors and Cardiovascular Outcomes Darren McGuire, MD, MHSc; Cindy Lamendola RN, MS, ANP |
11:30 AM | GLP1 Agonists and Cardiovascular Outcomes Eryn Bryant, RN, MS, ANP |
12:00 PM | Break |
12:15 PM | Non-CE Symposium from Boehringer Ingelheim Pharmaceuticals, Inc./Lilly USA - The Continuum of Heart Failure |
1:00 PM | Break |
1:15 PM | Inflammation and Cardiovascular Disease: Understanding the Relationship Donna Arnett, PhD |
2:00 PM | Oral Abstract Presentation Innovative Project: Matters of the Heart – Navigating Resources to Assist Patients in Managing Cardiovascular Conditions Pat Jolley |
2:15 PM | Break |
2:30 PM | Current Trends in the Diagnosis and Management of Ischemic Heart Disease and Microvascular Angina Eileen Handberg, PhD, ARNP-BC, FACC |
3:15 PM | Day 1 Post-Assessment and Wrap-Up |
THURSDAY, MAY 21 | |
Start at 10:15 AM ET, 9:15 AM CT, 8:15 AM MT, and 7:15 AM PT | |
9:15 AM | Welcome: Key Learnings from Day 1 and Pre-Assessment Day 2 |
9:20 AM | Product Theater from Amgen Cardiovascular Patient Cases Janice McAlister, DNP, APRN, CLS |
10:05 AM | Break |
10:15 AM | Sex Differences in Prevention and Management of Heart Failure Mariell Jessup, MD |
11:00 AM | Lipid Management in 2020: The Role of Non-Statin Therapies Susan Halli-Demeter, RN, DNP, CLS |
11:45 AM | Break |
12:00 PM | Product Theater from Esperion - NEXLETOL: A New, Oral, Nonstatin Therapy for Lowering LDL-C Joyce L. Ross, MSN, CRNP, CS, FNLA, FPCNA |
12:45 PM | Break |
1:00 PM | Oral Poster Presentation Original Research: Symptoms, Functional Capacity, and Skeletal Muscle in Persons with Heart Failure with Preserved Ejection Fraction Brittany Butts PhD, RN |
1:15 PM | Optimal Nutrition for Cardiovascular Risk Reduction: What should we eat now? Catherine Christie, PhD, RDN, LDN, FADA, FPCNA |
2:05 PM | Review of COVID 19: Epidemiology and Cardiovascular Considerations Yvonne Commodore-Mensah PhD, MHS, RN FAHA, FPCNA |
2:50 PM | Day 2 Post-learning assessment and Wrap up |
Sponsors
PCNA would like to thank the following sponsors for helping to make our program possible:
Premier Sponsors
- Amgen, Inc.
- AstraZeneca Pharmaceuticals
- Boehringer Ingelheim Pharmaceuticals, Inc./Lilly USA
- Esperion Therapeutics, Inc.
- Janssen
Signature Sponsors
- Amarin
- Novo Nordisk, Inc.
- Pfizer-Merck Alliance
Supporting Sponsor
- American Heart Association Scientific Councils
- Cardiovascular and Stroke Nursing
- Epidemiology and Prevention
- Lifestyle and Cardiometabolic Health
- Kidney in Cardiovascular Disease
- Stroke
Questions? Contact us.
PCNA is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030602.